{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:56:07Z","timestamp":1792292167419,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["RN254781-333204"],"award-info":[{"award-number":["RN254781-333204"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13104-018-3890-8","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T22:00:44Z","timestamp":1541023244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Incidence of chronic myeloid leukemia in Calgary, Alberta, Canada"],"prefix":"10.1186","volume":"11","author":[{"given":"Leonard Tu","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Naugler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariborz","family":"Rashid-Kolvear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,1]]},"reference":[{"key":"3890_CR1","volume-title":"Cancer facts & figures\u00a02015","author":"American Cancer Society","year":"2015","unstructured":"American Cancer Society. Cancer facts & figures\u00a02015. Atlanta: American Cancer Society; 2015."},{"issue":"6","key":"3890_CR2","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/cncr.21756","volume":"106","author":"JE Cortes","year":"2006","unstructured":"Cortes JE, Talpaz M, O\u2019Brien S, Faderl S, Garcia-Manero G, Ferrajoli A, et al. Staging of chronic myeloid leukemia in the imatinib era: an evaluation of the World Health Organization proposal. Cancer. 2006;106(6):1306\u201315.","journal-title":"Cancer"},{"issue":"3","key":"3890_CR3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.beha.2009.07.007","volume":"22","author":"M Rohrbacher","year":"2009","unstructured":"Rohrbacher M, Hasford J. Epidemiology of chronic myeloid leukaemia (CML). Best Pract Res Clin Haematol. 2009;22(3):295\u2013302.","journal-title":"Best Pract Res Clin Haematol."},{"issue":"3","key":"3890_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.canep.2013.01.002","volume":"37","author":"AM Mendizabal","year":"2013","unstructured":"Mendizabal AM, Garcia-Gonzalez P, Levine PH. Regional variations in age at diagnosis and overall survival among patients with chronic myeloid leukemia from low and middle income countries. Cancer Epidemiol. 2013;37(3):247\u201354.","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"3890_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12185-008-0230-0","volume":"89","author":"WY Au","year":"2009","unstructured":"Au WY, Caguioa PB, Chuah C, Hsu SC, Jootar S, Kim DW, et al. Chronic myeloid leukemia in Asia. Int J Hematol. 2009;89(1):14\u201323.","journal-title":"Int J Hematol"},{"issue":"Suppl 2","key":"3890_CR6","doi-asserted-by":"publisher","first-page":"S241","DOI":"10.1007\/s00277-015-2314-2","volume":"94","author":"M Hoglund","year":"2015","unstructured":"Hoglund M, Sandin F, Simonsson B. Epidemiology of chronic myeloid leukaemia: an update. Ann Hematol. 2015;94(Suppl 2):S241\u20137.","journal-title":"Ann Hematol"},{"issue":"3","key":"3890_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1667\/RR2892.1","volume":"179","author":"WL Hsu","year":"2013","unstructured":"Hsu WL, Preston DL, Soda M, Sugiyama H, Funamoto S, Kodama K, et al. The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950\u20132001. Radiat Res. 2013;179(3):361\u201382.","journal-title":"Radiat Res"},{"issue":"5","key":"3890_CR8","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1158\/1055-9965.EPI-13-0093","volume":"22","author":"GC Kabat","year":"2013","unstructured":"Kabat GC, Wu JW, Moore SC, Morton LM, Park Y, Hollenbeck AR, et al. Lifestyle and dietary factors in relation to risk of chronic myeloid leukemia in the NIH-AARP Diet and Health Study. Cancer Epidemiol Biomarkers Prev. 2013;22(5):848\u201354.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"13","key":"3890_CR9","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1002\/cncr.30636","volume":"123","author":"M Lauseker","year":"2017","unstructured":"Lauseker M, Hasford J, Saussele S, Kremers S, Kraemer D, Linemann W, et al. Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature death. Cancer. 2017;123(13):2467\u201371.","journal-title":"Cancer"},{"issue":"2","key":"3890_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3109\/07357908909038285","volume":"7","author":"D Leibowitz","year":"1989","unstructured":"Leibowitz D, Young KS. The molecular biology of CML: a review. Cancer Invest. 1989;7(2):195\u2013203.","journal-title":"Cancer Invest"},{"issue":"6","key":"3890_CR11","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1177\/2040620715607416","volume":"6","author":"S Giri","year":"2015","unstructured":"Giri S, Pathak R, Martin MG, Bhatt VR. Characteristics and survival of BCR\/ABL negative chronic myeloid leukemia: a retrospective analysis of the surveillance, epidemiology and end results database. Ther Adv Hematol. 2015;6(6):308\u201312.","journal-title":"Ther Adv Hematol."},{"issue":"9020","key":"3890_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0140-6736(05)64600-4","volume":"348","author":"J Dudley","year":"1996","unstructured":"Dudley J, Chambers T. Why the resistance to diagnostic imaging in childhood urinary tract infections. Lancet. 1996;348(9020):71\u20132.","journal-title":"Lancet"},{"issue":"3","key":"3890_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1586\/14737140.2016.1151356","volume":"16","author":"G Stagno","year":"2016","unstructured":"Stagno G, Stella S, Spitaleri A, Pennisi MS, Di Raimondo F, Vigneri P. Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomes. Expert Rev Anticancer Ther. 2016;16(3):273\u20138.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"6","key":"3890_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.clml.2015.03.006","volume":"15","author":"E Jabbour","year":"2015","unstructured":"Jabbour E, Kantarjian H, Cortes J. Use of second- and third-generation tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia: an evolving treatment paradigm. Clin Lymphoma Myeloma Leuk. 2015;15(6):323\u201334.","journal-title":"Clin Lymphoma Myeloma Leuk."},{"issue":"24","key":"3890_CR15","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1200\/JCO.2015.66.2866","volume":"34","author":"H Bower","year":"2016","unstructured":"Bower H, Bjorkholm M, Dickman PW, Hoglund M, Lambert PC, Andersson TM. Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population. J Clin Oncol. 2016;34(24):2851\u20137.","journal-title":"J Clin Oncol"},{"issue":"4","key":"3890_CR16","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3109\/0284186X.2012.707784","volume":"52","author":"E Mandal","year":"2013","unstructured":"Mandal E, Bolt DM, Shah BK. Disparities in chronic myeloid leukemia survival by age, gender, and ethnicity in pre- and post-imatinib eras in the US. Acta Oncol. 2013;52(4):837\u201341.","journal-title":"Acta Oncol"},{"issue":"3","key":"3890_CR17","first-page":"83","volume":"102","author":"E Sabattini","year":"2010","unstructured":"Sabattini E, Bacci F, Sagramoso C, Pileri SA. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica. 2010;102(3):83\u20137.","journal-title":"Pathologica."},{"key":"3890_CR18","unstructured":"Statistics Canada. Table\u00a017-10-0078-01 Annual demographic estimates by census metropolitan area, age and sex, based on the Standard Geographical Classification (SGC). 2011. \n                    https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1710007801\n                    \n                  . Accessed 3 Oct 2018."},{"key":"3890_CR19","first-page":"99","volume-title":"Cancer incidence in five continents, IARC scientific publication no160","author":"M Boniol","year":"2008","unstructured":"Boniol M, Heanue M. Age-standardisation and denominators. In: Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P, editors. Cancer incidence in five continents, IARC scientific publication no160, vol. 9. Lyon: International Agency for Research on Cancer, World Health Organization; 2008. p. 99\u2013101."},{"key":"3890_CR20","unstructured":"Statistics Canada. Table\u00a017-10-0005-01 Population estimates on July 1st, by age and sex. \n                    https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1710000501\n                    \n                  . Accessed 3 Oct 2018."},{"issue":"3","key":"3890_CR21","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1158\/1055-9965.EPI-11-1087","volume":"21","author":"BM Craig","year":"2012","unstructured":"Craig BM, Rollison DE, List AF, Cogle CR. Underreporting of myeloid malignancies by United States cancer registries. Cancer Epidemiol Biomarkers Prev. 2012;21(3):474\u201381.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"3890_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4062\/biomolther.2018.103","volume":"26","author":"HI Kim","year":"2018","unstructured":"Kim HI, Lim H, Moon A. Sex differences in cancer: epidemiology, genetics and therapy. Biomol Ther (Seoul). 2018;26(4):335\u201342.","journal-title":"Biomol Ther (Seoul)"},{"issue":"7","key":"3890_CR23","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.3109\/10428194.2012.745525","volume":"54","author":"Y Chen","year":"2013","unstructured":"Chen Y, Wang H, Kantarjian H, Cortes J. Trends in chronic myeloid leukemia incidence and survival in the United States from 1975 to 2009. Leuk Lymphoma. 2013;54(7):1411\u20137.","journal-title":"Leuk Lymphoma"},{"issue":"19","key":"3890_CR24","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1182\/blood-2010-05-282632","volume":"116","author":"M Sant","year":"2010","unstructured":"Sant M, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Visser O, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010;116(19):3724\u201334.","journal-title":"Blood"},{"issue":"6","key":"3890_CR25","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.rce.2016.03.001","volume":"216","author":"S Osorio","year":"2016","unstructured":"Osorio S, Casado LF, Giraldo P, Maestro B, Andrade M, Redondo S, et al. Chronic myeloid leukaemia in Spain: its presentation characteristics have changed. Spanish section of the EUTOS population-based registry. Rev Clin Esp. 2016;216(6):293\u2013300.","journal-title":"Rev Clin Esp."},{"issue":"11","key":"3890_CR26","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/bjc.2011.450","volume":"105","author":"A Smith","year":"2011","unstructured":"Smith A, Howell D, Patmore R, Jack A, Roman E. Incidence of haematological malignancy by sub-type: a report from the haematological malignancy research network. Br J Cancer. 2011;105(11):1684\u201392.","journal-title":"Br J Cancer"},{"key":"3890_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12885-016-2238-9","volume":"16","author":"T Beinortas","year":"2016","unstructured":"Beinortas T, Tavoriene I, Zvirblis T, Gerbutavicius R, Jurgutis M, Griskevicius L. Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000\u20132013. BMC Cancer. 2016;16:198.","journal-title":"BMC Cancer."},{"issue":"7","key":"3890_CR28","first-page":"24","volume":"86","author":"SM Kulikov","year":"2014","unstructured":"Kulikov SM, Vinogradova O, Chelysheva E, Tishchenko IA, Galaiko MA, Lazareva OV, et al. [Incidence of chronic myeloid leukemia in 6 regions of Russia according to the data of the 2009\u20132012 population-based study]. Ter Arkh. 2014;86(7):24\u201330 (Russian).","journal-title":"Ter Arkh"},{"issue":"2","key":"3890_CR29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4103\/0971-5851.89792","volume":"32","author":"RP Dikshit","year":"2011","unstructured":"Dikshit RP, Nagrani R, Yeole B, Koyande S, Banawali S. Changing trends of chronic myeloid leukemia in greater Mumbai, India over a period of 30\u00a0years. Indian J Med Paediatr Oncol. 2011;32(2):96\u2013100.","journal-title":"Indian J Med Paediatr Oncol."}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-018-3890-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13104-018-3890-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-018-3890-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T05:45:29Z","timestamp":1572587129000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-018-3890-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3890"],"URL":"https:\/\/doi.org\/10.1186\/s13104-018-3890-8","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,1]]},"assertion":[{"value":"9 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"780"}}